|
|
|
|
|
by nbevans
2038 days ago
|
|
I'd argue that it is more accessible to everyone including developed nations. It only requires a standard technology freezer - like that you have in a residential home. COVID-19 has already cost the UK hundreds of billions, so being able to roll out a vaccine with minimum hassle and without needing specialist storage and training on its handling, is an absolutely enormous benefit. Honestly I feel like this vaccine is going to leave the mRNA-based vaccines trailing in its wake in terms of global government adoption. |
|
However for developing world the prices becomes the issue, so you are probably right, this vaccine is cheaper and thus more available.
[1]: https://www.nationalgeographic.com/science/2020/11/moderna-e...